Editor's Note Sandia National Laboratories (Albuquerque, New Mexico), one of three National Nuclear Security Administration research and development laboratories in the US, announced on June 22 that it is partnering with hospitals and device manufacturers to increase the availability of respirator masks for healthcare workers. Sandia is helping manufacturers test…
Editor's Note In this retrospective study, researchers from the French Society of Neuroradiology found three main brain MRI patterns in patients with severe COVID-19. The analysis of 37 patients from 16 centers found: signal abnormalities in the medial temporal lobe (43%), an area of the brain related to cognitive and…
Editor's Note The Joint Commission announced June 17 that it has resumed limited survey activities this month, and that scoring of items that are not compliant will not be the primary focus during the COVID-19 public health emergency. However, the Joint Commission says, there are several elements of performance (EPs)…
Editor's Note Patients with underling conditions, such as heart disease, chronic lung disease, and diabetes were hospitalized six times as often and died 12 times as often from COVID-19 as those without underlying conditions, the Centers for Disease Control and Infection (CDC) reports. Severe outcomes increased with age—the percentages of…
Editor's Note The Cleveland Clinic announced June 15 that its researchers have developed the world’s first model to predict the likelihood of patients testing positive for COVID-19 and their outcomes from the disease. The model was based on data from nearly 12,000 patients in the Cleveland Clinic’s COVID-19 Registry, including…
Editor's Note A regional, coalition-guided, multifaceted approach that engaged healthcare systems, long-term care facilities, state and local governments, and organizations to rapidly respond to the COVID-19 outbreak, kept Washington State’s death rate the lowest of all states with major outbreaks, this study finds. Six key factors helped “flatten the curve:”…
Editor's Note In preliminary results of this study from the University of Oxford, UK, a low-cost steroid, dexamethasone, reduced deaths by up to one third in hospitalized patients with severe respiratory complications of COVID-19. A total of 2,104 patients were randomized to receive dexamethasone 6 mg once per day for…
Resuming elective surgical procedures is critical for recovering revenue lost during the early phase of the COVID-19 pandemic and treating patients whose health may have been compromised while awaiting surgery. Timetables and protocols for resuming those procedures tend to differ by facility, but OR leaders nationwide feel that “we’re all…
Editor’s note: This editorial is by Judy Mathias, OR Manager’s clinical editor. It is adapted from remarks made in a webinar presented by DLA Piper in partnership with the Cohen Group, titled, “Looking forward: COVID-19 and its implications for global business and international cooperation.” The speakers were General James Mattis,…
As state authorities begin to ease restrictions imposed by COVID-19, physicians, nurse leaders, and administrators face a momentous challenge: resuming elective surgical procedures that have been postponed for several weeks or months. How will they accommodate the looming glut of elective surgery demand with limited infrastructure and staff who are…